Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Laboratory Features of Trichinellosis and Eosinophilia Threshold Determined

By LabMedica International staff writers
Posted on 01 Dec 2022

Trichinella nativa is a nematode worm, one of the species of the genus Trichinella, found in arctic and subarctic regions. More...

It is highly pathogenic and has a high resistance to freezing. It is encapsulated, and infects a wide variety of mammals and birds.

T. nativa is a species commonly found in omnivores and carnivores such as wild boars, foxes, raccoon dogs and bears. In the Arctic, the corpses of animals that die may get frozen and later be consumed by scavengers. This worm remains viable even after being frozen at −18 °C for four years. Eosinophilia is a well-characterized feature of infection that is readily available for most cases.

Infectious Disease Scientists at the McGill University Health Centre (Montreal, QC, Canada) and their colleagues reviewed all requests for Trichinella serologic testing sent from Quebec to the National Reference Centre for Parasitology (Toronto, ON, Canada). They identified 43 cases of trichinellosis and a set of 31 region-matched controls. Information on signs and symptoms was available for only 19/43 case-patients, but demographic, laboratory, and clinical outcomes were well documented. Case-patients had a median age of 40 years and were mostly female (30/43, 69.8%).

Laboratory information was available for 41/43 case-patients. Features of Trichinella infection presumptively caused by T. nativa, are similar to those reported for T. spiralis infection, including elevated creatinine kinase and eosinophilia. The variable that differed most between cases and controls was peak absolute eosinophilia (5.35 versus 0.80 × 109 cells/L). Using ROC analysis, they identified an absolute eosinophilia threshold of >0.8 × 109 cells/L, which identified all cases in this series with a specificity of 71%.

The authors noted that automated flags and reflex testing in the local laboratory has now incorporated the threshold identified in their analysis. In the absence of a defined alternative diagnosis, eosinophil counts of >0.80 ×109 cells/L should prompt clinical consideration of trichinellosis and further investigation. The study was published in the November 2022 edition of the journal Emerging Infectious Diseases.

Related Links:
McGill University Health Centre
National Reference Centre for Parasitology 


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.